相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
Chunlin Li et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer
Lucy Ireland et al.
ONCOGENE (2018)
Combinatorial immunotherapy for melanoma
D. D. George et al.
CANCER GENE THERAPY (2017)
The biological function and significance of CD74 in immune diseases
Huiting Su et al.
INFLAMMATION RESEARCH (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy
B. A. Castro et al.
ONCOGENE (2017)
Coinhibitory Receptor expression and immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic viral infections and Cancer
Isobel S. Okoye et al.
FRONTIERS IN IMMUNOLOGY (2017)
Indicators of responsiveness to immune checkpoint inhibitors
Bradley D. Shields et al.
SCIENTIFIC REPORTS (2017)
MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation
Kavitha Yaddanapudi et al.
CANCER IMMUNOLOGY RESEARCH (2016)
The multifaceted roles of the invariant chain CD74-More than just a chaperone
Bernd Schroeder
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling
Jian-Ming Li et al.
CANCER RESEARCH (2016)
Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
Lucy Ireland et al.
CANCER RESEARCH (2016)
Predicted structure of MIF/CD74 and RTL1000/CD74 complexes
Roberto Meza-Romero et al.
METABOLIC BRAIN DISEASE (2016)
Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis
Sebastian R. Nielsen et al.
NATURE CELL BIOLOGY (2016)
MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis
A. Ghoochani et al.
ONCOGENE (2016)
Uveal melanoma as a target for immune-therapy
Marc Oliva et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes
Sabine Waigel et al.
GENOMICS DATA (2016)
Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy
Hao-Nan Chang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth
Tao Wang et al.
CLINICAL CANCER RESEARCH (2015)
Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial
Michele Maio et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Future perspectives in melanoma research: meeting report from the Melanoma Bridge: Napoli, December 3rd-6th 2014
Paolo A. Ascierto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa-Silva et al.
NATURE CELL BIOLOGY (2015)
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo
Carlos R. Figueiredo et al.
SCIENTIFIC REPORTS (2015)
Melanoma
Dirk Schadendorf et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas
Pia S. Zeiner et al.
BRAIN PATHOLOGY (2015)
Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma
Camila S. Oliveira et al.
BMC CANCER (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy (vol 41, pg 49, 2014)
Roy Noy et al.
IMMUNITY (2014)
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis
Roberto Meza-Romero et al.
JOURNAL OF IMMUNOLOGY (2014)
Anti-tumor activities of peptides corresponding to conserved complementary determining regions from different immunoglobulins
Carlos R. Figueiredo et al.
PEPTIDES (2014)
T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
Ignacio Melero et al.
CANCER DISCOVERY (2014)
Impact of tumour associated macrophages in pancreatic cancer
Ainhoa Mielgo et al.
BMB REPORTS (2013)
Metastatic Volume: An Old Oncologic Concept and a New Prognostic Factor for Stage IV Melanoma Patients
V. Panasiti et al.
DERMATOLOGY (2013)
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects
Gil Benedek et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Kinase AKT controls innate immune cell development and function
Yan Zhang et al.
IMMUNOLOGY (2013)
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma
Naotake Funamizu et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A novel regulatory pathway for autoimmune disease: Binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance
Arthur A. Vandenbark et al.
JOURNAL OF AUTOIMMUNITY (2013)
Control of Tumor-Associated Macrophage Alternative Activation by Macrophage Migration Inhibitory Factor
Kavitha Yaddanapudi et al.
JOURNAL OF IMMUNOLOGY (2013)
Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo
Filza Hussain et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells
Mario Hubo et al.
FRONTIERS IN IMMUNOLOGY (2013)
Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides
Aron Roxin et al.
FUTURE MEDICINAL CHEMISTRY (2012)
β-Actin-binding Complementarity-determining Region 2 of Variable Heavy Chain from Monoclonal Antibody C7 Induces Apoptosis in Several Human Tumor Cells and Is Protective against Metastatic Melanoma
Denise C. Arruda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Macrophage Migration Inhibitory Factor Promotes Tumor Growth and Metastasis by Inducing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kendra D. Simpson et al.
JOURNAL OF IMMUNOLOGY (2012)
PepSite: prediction of peptide-binding sites from protein surfaces
Leonardo G. Trabuco et al.
NUCLEIC ACIDS RESEARCH (2012)
Antibody peptide based antifungal immunotherapy
Walter Magliani et al.
FRONTIERS IN MICROBIOLOGY (2012)
Regulatory dendritic cells: there is more than just immune activation
Susanne V. Schmidt et al.
FRONTIERS IN IMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
A Concerted Mechanism for Opening the GDP Binding Pocket and Release of the Nucleotide in Hetero-Trimeric G-Proteins
Maxime Louet et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Milatuzumab - a promising new immunotherapeutic agent
Zuzana Berkova et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Immunogenic Versus Tolerogenic Dendritic Cells: A Matter of Maturation
Roland Tisch
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2010)
Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells
Andrey S. Dobroff et al.
TRANSLATIONAL ONCOLOGY (2010)
Antibodies as Crypts of Antiinfective and Antitumor Peptides
W. Magliani et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Collective motions in Glucosamine-6-phosphate Synthase: Influence of Ligand Binding and role in Ammonia Channelling and Opening of the Fructose-6-Phosphate Binding Site
Nicolas Floquet et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity
Elena Gabrielli et al.
PLOS ONE (2009)
Differential development of murine dendritic cells by GM-CSF versus flt3 ligand has implications for inflammation and trafficking
Yuekang Xu et al.
JOURNAL OF IMMUNOLOGY (2007)
Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells
Katherine L. Meyer-Siegler et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation
Xiaocai Yan et al.
CYTOKINE (2006)
ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis
Y Al-Abed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane
A Chow et al.
NATURE (2002)
Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells
AC Repp et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
